Skip to content
Journal

Documentation

A Canadian research buyer’s documentation checklist

By Proof Line Peptides · Published · 1 min read

Before comparing prices, confirm that the listing identifies the material, the quantity, and any document tied to the specific lot. A short, repeatable checklist makes omissions visible without turning marketing language into evidence.

Start with identifiers you can reconcile

Record the displayed compound name, stated milligrams, whether it is a single compound or a blend, and the date you reviewed the page. If a report is provided, compare its product and lot identifiers with the physical label. A generic example report cannot establish results for another lot.

Use a pre-purchase record

ListingName, components, quantity, price in CAD
DocumentLot identifier, report date, named methods and reporting laboratory
ScopeWhat each result measures — and what it does not
OperationsOnly confirmed storage, payment and shipping details

Keep authorization questions separate

A research-use listing is not evidence of authorization as a medicine. For a Canadian drug, check the specific product record in Health Canada’s database. An ingredient-name match alone does not connect an unrelated vial to that authorization. [Health Canada Drug Product Database]

Read omissions literally

When a listing does not state a specification, record it as “not stated.” Do not fill the gap with assumptions based on another seller, a similar label or a category name. Screenshots and dated notes make later comparisons easier when listings change.

Final check

  • Save the listing and the supplied instructions.
  • Reject unsupported assumptions about sterility, origin or performance.
  • Ask for clarification when identifiers conflict or a specification is absent.

References

  1. Health Canada. Drug Product Database: the official list of drug products authorized for sale in Canada. View source
  2. GenScript technical overview of peptide quality attributes. View source